Imviva Biotech Announces Seven Presentations Highlighting its ANSWER(TM) Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting

Two oral, and five poster presentations will showcase the company's progress in developing allogenic cell therapy candidates for multiple hematological malignancies CTD402 data for the treatment of T-ALL/LBL selected as a landmark study to be highlighted during 2026 ASH Highlights BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Imviva Biotech, a clinical-stage biotechnology company developing next-generation […]

Research Frontiers Highlights Rising Industry Momentum for SPD-SmartGlass Following Chairman’s Keynote Address at Detroit Automotive Glazing Summit

(NASDAQ:REFR),(NasdaqGM:GAUZ), WOODBURY, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) — Research Frontiers Inc. (Nasdaq: REFR) highlighted the strong industry interest in SPD-SmartGlass at last week's ECV Automotive Glazing Summit in Detroit, where Research Frontiers President & CEO Joseph M. Harary served as Chairman of the event and delivered the keynote address. The summit brought together automakers,

Jyong Biotech Ltd. Signs Non‒Binding Letter of Intent with Leading South Korean Pharmaceutical Company to Evaluate In‒Licensing of Plant-Derived MCS Drugs

(NasdaqGM:MENS), New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets

Waton Financial Limited Expands Partnership with Panda AI, Exploring Joint Venture to Advance AI Agent Applications in Financial Services

(NASDAQ:WTF), HONG KONG, Nov. 24, 2025 (GLOBE NEWSWIRE) — Waton Financial Limited (NASDAQ: WTF), a securities brokerage and financial technology group (“Waton” or the “Company”), today announced an expanded strategic partnership with Chongqing Liangyun Zhijing Information Technology Limited (“Panda AI”), an AI agent development platform, to explore the formation of a joint venture, subject to

Amaze and Loft 100 Studios Partner to Bring World-Class Live Production Studios to Creators

(NYSE MKT:AMZE), NEWPORT BEACH, Calif, Nov. 24, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, has partnered with Loft 100 Studios to power its new Creator Studio, a fully equipped, state-of-the-art production facility for creators to record, produce, and scale high-quality content. The studio is located

NeoVolta Enters into Definitive Agreements Led by Infinite Grid Capital to Advance 2 GWh U.S. Battery Energy Storage System Manufacturing Initiative

(NASDAQ:NEOV), SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company“), a U.S.-based energy technology company delivering scalable storage for resilient residential and commercial power infrastructure, today announced that it has entered into agreements for a $13 million private placement financing anchored by Infinite Grid Capital (“IGC”), in connection

U.S. Navy Awards SAIC $242M Contract to Operate, Maintain and Upgrade Propulsion Test Facility

(NASDAQ:SAIC), RESTON, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) — Science Applications International Corp. (NASDAQ: SAIC) has been awarded a $242 million contract by the Naval Undersea Warfare Center Division, Newport (NUWCDIVNPT) to enable the continued operation, maintenance and modernization of the Propulsion Test Facility (PTF), in support of the Undersea Warfare (USW) Weapons, Vehicles and

Menarini Group Announces New Data on ELZONRIS(R) (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN). BPDCN is a highly aggressive, orphan hematologic malignancy that primarily affects skin, bone marrow, and blood. FLORENCE, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — The Menarini Group (“Menarini”), a leading international pharmaceutical and

Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform

(NASDAQ:GELS), MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) — Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced positive preclinical results showing its proprietary gel formulation achieved substantially higher bioavailability than a leading on-market reference antihistamine product. In a comparative pharmacokinetic study, Gelteq's formulation demonstrated

InterDigital awarded injunction against Disney by German court

(NASDAQ:IDCC), WILMINGTON, Del., Nov. 24, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced it has been awarded another injunction against Disney by a court in Germany. The Munich Regional Court ruled that InterDigital is entitled to an injunction over Disney's infringement of an

Scroll to Top